USA – BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas under investigation. The three-year extension…
Read MoreBenevolentAI announces 3-year collaboration expansion with AstraZeneca
